Benzinga | Sep 27, 2021 08:55AM EDT

Craig-Hallum Maintains Buy on Repligen, Raises Price Target to $368

Craig-Hallum analyst Matt Hewitt maintains Repligen (NASDAQ:RGEN) with a Buy and raises the price target from $258 to $368.